Michael L. Hall
No más puestos en curso
Perfil
Michael L.
Hall served as Chief Medical Officer & SVP-Regulatory Affairs at Repligen Corp.
in 2011, Senior Vice President-Clinical Development at Ironwood Pharmaceuticals, Inc., Chief Medical Affairs at Novartis Pharmaceuticals Corp., and Vice President at Shire Human Genetic Therapies, Inc. He holds a doctorate degree from the University of the Witwatersrand.
Antiguos cargos conocidos de Michael L. Hall.
Empresas | Cargo | Fin |
---|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Director Técnico/Científico/I+D | - |
IRONWOOD PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
REPLIGEN CORPORATION | Director Técnico/Científico/I+D | - |
Formación de Michael L. Hall.
University of the Witwatersrand | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
REPLIGEN CORPORATION | Health Technology |
IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Michael L. Hall